Transplantation cardiaque et VO2max: faut-il revoir les seuils?
d’obtenir un test maximal. Pour les patients ayant des pics de
VO2> 12 mL/kg/min, d’autres critères tels que la pente
VE/VCO2peuvent être des facteurs prédictifs additionnels
avec un seuil à 35.
Dans tous les cas, la décision d’inscription sur liste de trans-
plantation cardiaque ne se conçoit que sur un faisceau d’ar-
guments cliniques, échographiques, biologiques, dont
l’épreuve d’effort fait partie, en sachant qu’un des critères
puissant du pronostic est l’incapacité cardiaque à réaliser une
épreuve d’effort. ■
Bibliographie
1. TAYLOR DO, EDWARDS LB, BOUCEK MM et al. Registry of the Interna-
tional Society for Heart and Lung Transplantation : twenty-third official
adult heart transplantation report – 2006. J Heart Lung Transplant, 2006 ;
25 : 869-79.
2. MANCINI DM, EISEN H, KUSSMAUL Wet al. Value of peak exercise oxygen
consumption for optimal timing of cardiac transplantation in ambulatory
patients with heart failure. Circulation, 1991 ; 83 : 778-86.
3. MILLER LW, KUBO SH, YOUNG JB et al. Report of the consensus confe-
rence on candidate selection for Heart Transplantation – 1993. J Heart Lung
Transplant, 1995 ; 14 : 562-71.
4. OPASICH C, PINNA GD, BOBBIO Met al. Peak exercise oxygen consumption
in chronic heart failure : toward efficient use in the individual patient. J Am
Coll Cardiol, 1998 ; 31 : 766-75.
5. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) : a randomised
trial. Lancet, 1999 ; 353 : 9-13.
6. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL
Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
Lancet, 1999 ; 353 : 2001-7.
7. METRA M, GIUBBINI R, NODARI S et al. Differential effects of beta-blockers
in patients with heart failure : A prospective, randomized, double-blind com-
parison of the long-term effects of metoprolol versus carvedilol. Circulation,
2000 ; 102 : 546-51.
8. SHAKAR SF, LOWES BD, LINDENFELD Jet al. Peak oxygen consumption and
outcome in heart failure patients chronically treated with beta-blockers.
J Card Fail, 2004 ; 10 : 15-20.
9. PETERSON LR, SCHECHTMAN KB, EWALD GA et al. Timing of cardiac trans-
plantation in patients with heart failure receiving beta-adrenergic blockers.
J Heart Lung Transplant, 2003; 22: 1141-8.
10. O’NEILL JO, YOUNG JB, POTHIER CE et al. Peak oxygen consumption as
a predictor of death in patients with heart failure receiving beta-blockers. Cir-
culation, 2005 ; 111 : 2 313-8.
11. MEHRA MR, KOBASHIGAWA J, STARLING Ret al. Listing criteria for heart
transplantation : International Society for Heart and Lung Transplantation
guidelines for the care of cardiac transplant candidates – 2006. J Heart Lung
Transplant, 2006 ; 25 : 1 024-42.
12. ARENA R, MYERS J, ASLAM SS et al. Peak VO2 and VE/VCO2slope in patients
with heart failure: a prognostic comparison. Am Heart J, 2004; 147: 354-60.
13. FRANCIS DP, SHAMIM W, DAVIES LC et al. Cardiopulmonary exercise testing
for prognosis in chronic heart failure: continuous and independent prognostic
value from VE/VCO2slope and peak VO2. Eur Heart J, 2000; 21: 154-61.
14. CORRA U, MEZZANI A, BOSIMINI Eet al. Ventilatory response to exercise
improves risk stratification in patients with chronic heart failure and inter-
mediate functional capacity. Am Heart J, 2002 ; 143 : 418-26.
15. MEZZANI A, CORRA U, BOSIMINI Eet al. Contribution of peak respiratory
exchange ratio to peak VO2prognostic reliability in patients with chronic heart
failure and severely reduced exercise capacity. Am Heart J, 2003 ; 145 : 1102-7.
16. CORRA U, MEZZANI A, BOSIMINI Eet al. Cardiopulmonary exercise tes-
ting and prognosis in chronic heart failure : a prognosticating algorithm for
the individual patient. Chest, 2004 ; 126 : 942-50.
17. OSMAN AF, MEHRA MR, LAVIE CJ et al. The incremental prognostic
importance of body fat adjusted peak oxygen consumption in chronic heart
failure. J Am Coll Cardiol, 2000; 36: 2126-31.